NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis

NCT01961310

CompletedN/A

Sponsor: Centre Hospitalier Universitaire de Nīmes

Conditions: Arthritis, Rheumatoid

Interventions: Plasma analysis for bacterial translocation, Stool analysis

Countries: France

The main objective of this study is to compare the intestinal microbiota in newly diagnosed rheumatoid arthritis (RA) with that from individuals without RA. The first analysis will compare the proportion of filamentous bacteria in the intestinal microbiota between the two groups.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria for RA patients:

* The patient was correctly informed
* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* No antibiotic treatments within the 30 days preceding inclusion
* Absence of digestive pathology
* RA diagnosis made within the past 12 months

Exclusion Criteria for RA patients:

* The patient has participated in another study within the past 3 months
* The patient is under judicial protection, or any kind of guardianship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The patient is pregnant, parturient, or breastfeeding
* The patient has taken antibiotics in the 30 days preceding inclusion
* RA was diagnosed more than 12 months ago
* Digestive pathology

Inclusion Criteria for healthy volunteers (HV):

* The HV was correctly informed
* The HV must have given his/her informed and signed consent
* The HV must be insured or beneficiary of a health insurance plan
* Absence of digestive pathology
* No antibiotic treatments within the 30 days preceding inclusion
* Does not have RA

Exclusion Criteria for HVs:

* The HV has participated in another study within the past 3 months
* The HV is under judicial protection, or any kind of guardianship
* The HV refuses to sign the consent
* It is impossible to correctly inform the HV
* The HV is pregnant, parturient, or breastfeeding
* The HV has taken antibiotics in the 30 days preceding inclusion
* Digestive pathology
* Joint pathology of any kind (including inflammatory pathologies)
Locations (3)
  • Montpellier, France
  • Nîmes, France
  • Nîmes, France